18 Share Tips – 15th December 2025

Welcome to this week’s edition of 18 Share Tips – our weekly selection of top ASX shares, chosen by leading analysts, that we think are worth considering.

This week Elio D’Amato of EnviroInvest, Andrew Wielandt of DP Wealth Advisory and Tony Locantro of Alto Capital share their ‘Buy’, ‘Hold’ and ‘Sell’ recommendations.

Please note these share tips are simply recommendations and are in no way intended as financial advice. These share tips are general advice and don’t take into account any individual’s financial situation. Investors are advised to seek professional financial advice before investing.

Sign up to our mailing list and get our weekly batch of share tips sent straight to your inbox, every Monday.

Early Access to 18 Share Tips

Every Monday at 9AM, thousands of investors scramble to read the same tips at the same time. Prices move. Opportunities disappear. You’re always one step behind.

But with The Bull Premium you get access to 18 Share Tips on Friday morning, giving you 3 extra days to prepare.

So while others read Monday’s tips, you’re already positioned to win.

Elio D’Amato, EnviroInvest

BUY RECOMMENDATIONS

BUY – Ansell (ANN)

Ansell makes personal protection equipment for healthcare and industrial workplaces. Organic sales growth, efficiency gains and favourable foreign exchange movements supported upgraded earnings per share guidance to between $US1.37 and $US1.49 in fiscal year 2026. The balance sheet remains sound, and margin momentum is improving across its healthcare and industrial divisions. Environmentally, ANN benefits from tightening global sustainability standards in personal protective equipment procurement and ongoing investment in cleaner manufacturing processes. ANN intends to be net zero, including scope 3 emissions, by 2045. ANN offers defensive earnings, improving cash flow prospects and attractive re-rating potential.

BUY – Vulcan Energy Resources (VUL)

Vulcan recently secured a €2.2 billion ($A3.929 billion) financing package to fully fund phase one of its Lionheart project, It’s Europe’s first fully integrated, zero carbon lithium and renewable energy project. Funding enables immediate construction. The package includes €1.185 billion in senior debt, €204 million in German government grants, €150 million from KfW, plus strategic equity from HOCHTIEF, Siemens and Demeter. Phase one targets 24,000 tonnes of lithium hydroxide per year. With funding risk removed and execution underway, VUL’s strategic positioning is materially stronger.

HOLD RECOMMENDATIONS

HOLD – Calix (CXL)

Calix continues to advance its Leilac decarbonisation technology. CXL generated revenue and other income of $33.9 million in full year 2025, up 11 per cent on the prior corresponding period. EBITDA remains negative as scale-up investment continues. European Union backed cement projects are progressing, but meaningful revenue remains a medium term prospect. CXL has a large decarbonisation opportunity, yet the valuation already prices in long-dated options. Cash burn persists despite developments, such as the Zesty Green Iron Demonstration Plant agreement with Rio Tinto. CXL is suitable for patient holders. The shares have risen from 39 cents on November 7 to trade at 53.5 cents on December 11.

HOLD – Mercury NZ (MCY)

This major New Zealand electricity generator and retailer operates an almost entirely renewable portfolio across hydro, wind and geothermal assets. In full year 2025, EBITDAF of $NZ786 million fell 10 per cent in difficult operating conditions. Its latest operational update was positive in response to strong energy generation. We consider MCY a solid income and defensive clean energy holding.

SELL RECOMMENDATIONS

SELL – CSL (CSL)

I recommended selling CSL in TheBull.com.au in February 2025 after the biotechnology giant posted a lacklustre first half result in fiscal year 2025, in my view. The shares have substantially fallen from $261 on February 24. The stock was trading at $178.83 on December 11. CSL recently cut revenue and profit growth forecasts for fiscal year 2026. The company’s vaccine division Seqirus is under pressure from declining vaccination rates in the United States. Plasma collection remains healthy, but integration costs involving CSL Vifor, a leader in iron deficiency and nephrology, amid restructuring expenses continue to weigh on margins and cash flow, in my view. In the absence of near-term catalysts and years of share price stagnation, capital could be better deployed elsewhere until the outlook  improves.

SELL – Provaris Energy (PV1)

Provaris is advancing compressed hydrogen and carbon dioxide storage and transport solutions through proprietary tank designs. No revenue was generated in the September quarter. Its compressed hydrogen shipping technology remains in engineering and regulatory stages. At the end of the September quarter, the company had $925,000 in cash amid continuing negative operating outflows. While the pathway is environmentally appealing and the European pivot is sensible, competing ammonia and pipeline transport solutions are progressing faster with deeper capital support. For now, capital is better allocated to clean energy developers with clearer timelines, in my opinion.

Andrew Wielandt, DP Wealth Advisory

BUY RECOMMENDATIONS

BUY – L1 Long Short Fund (LSF)

LSF invests in Australian and global shares. It holds long and short positions, enabling it to benefit from both rising and falling markets. LSF’s performance in the past 12 months has been strong. Exposure to a long and short style fund appeals given increasing market volatility and the potential for a correction following global sharemarket strength. LSF provides investors with additional diversification. I hold LSF in my self managed superannuation fund.

BUY – SGH Limited (SGH)

This diversified company focuses on industrial services and energy. Businesses include WesTrac, Coates and Boral, along with significant exposures to Beach Energy and Seven West Media. WesTrac is the sole  authorised Caterpillar dealer in Western Australia, New South Wales and the Australian Capital Territory. We expect the Caterpillar dealerships to benefit from strong expected demand in the resources sector. SGH should also benefit from equipment hire. Fiscal year 2026 guidance fell short of market expectations. Share price weakness provides a buying opportunity. The shares have fallen from $51.86 on August 11, the day prior to reporting full year 2025 results, to trade at $44.72 on December 11.

HOLD RECOMMENDATIONS

HOLD – Betashares Global Cybersecurity ETF (HACK)

This exchange traded fund focuses on the fast growing cyber security sector of the economy. It holds businesses, such as Broadcom, Palo Alto Networks and CrowdStrike Holdings. The fund has delivered a strong performance in the past five years in response to the favourable growth outlook for the cyber security industry. Companies and countries are bolstering their cyber security defences to counter the ever increasing threat of cyber crime. The cyber security industry offers significant growth potential. I hold HACK  in my self managed superannuation fund. 

HOLD – Judo Capital Holdings (JDO)

JDO provides banking services to small and medium sized (SME) businesses. Deposits of $9.9 billion at the end of fiscal year 2025 were up 20 per cent on the prior corresponding period. Deposits support its product offering, such as lines of credit, asset finance and business loans. JDO’s strategy revolves around capturing SME clients from major competitors and providing better service through offerings and location. Statutory net profit after tax of $86.4 million in fiscal year 2025 was up 24 per cent on the prior corresponding period.

SELL RECOMMENDATIONS

SELL – Bapcor (BAP)

Bapcor is an aftermarket automotive parts provider. It operates the Autobarn, Burson and Autopro brands. Shares recently hit a 12-month low after the company downgraded profit guidance. Bapcor expects to deliver a statutory net loss of between $5 million and $8 million in the first half of fiscal year 2026. Performance in the trade segment was below expectations in October and November. Revenue declined in tools and equipment when compared to the prior corresponding period. The shares have fallen from $5.11 on July 23 to trade at $1.792 on December 11. We retain a sell recommendation until there is clear evidence of an operational recovery.

SELL – Lendlease Group (LLC)

Lend Lease is a property developer and investment manager. The company is focusing on growing its Australian operations. The company has reduced debt and risk by divesting overseas projects and operations. However, in our view, this may lead to fewer development opportunities as it has less capital to recycle. The company expects fiscal year 2026 to be one of transition. The shares have fallen from $6.77 on February 17 to trade at $5.125 on December 11. We prefer to be on the sidelines at this point, while monitoring developments.  

Tony Locantro, Alto Capital

BUY RECOMMENDATIONS

BUY – Avecho Biotechnology (AVE)

The company’s lead asset is a proprietary cannabidiol (CBD) soft-gel capsule. Avecho has just secured patent allowances in the US and Europe for its soft-gel capsule, which is currently in phase III clinical development for insomnia. Patents on the allowed applications are expected by the end of 2026, which will protect soft-gel capsules in the US and Europe until at least 2040. Combined with an exclusive licensing deal with Sandoz Group AG in Australia, Avecho is positioned to become a leading CBD-insomnia drug player. Risks remain high with any early stage biotechnology company, but possible patents substantially raise potential upside in the event of trial success. The shares were trading at less than a cent on December 11.

BUY – Everest Metals Corporation (EMC)

Everest Metals is advancing its Mt Edon Critical Mineral project in Western Australia. It recently announced further high grade rubidium interim results from its phase 2 resource upgrade and expansion program. An engineering study, undertaken with Edith Cowan University, confirmed up to 97 per cent of rubidium recovery using its proprietary extraction method that’s now supported by provisional patent protection and grant funding from the Minerals Research Institute of Western Australia. Also, EMC has started resource upgrade drilling at the Mt Dimer Taipan Gold project, which provides another option to its critical minerals ambitions. A speculative buy with the shares priced at 12.5 cents on December 11.

HOLD RECOMMENDATIONS

HOLD – Brightstar Resources (BTR)

This gold company has just completed the takeover of Aurumin, consolidating its Sandstone region tenements and boosting its total resource to about 3.9 million ounces to 4 million ounces of gold. Brightstar delivered a record processing campaign amounting to 83,166 tonnes at 2.84 grams a tonne, yielding an estimated 6300 ounces of gold. With drilling and feasibility studies underway amid a production target of about 200,000 ounces per annum by 2029, upside is substantial, particularly if Sandstone’s potential is realised. However, we consider it speculative at this stage.

HOLD – Talisman Mining (TLM)

Talisman has launched a 2500 metre aircore drilling program at the Walkers Hill Gold project, testing high‑tenor gold‑in‑soil trends. Also, TLM has started a 900 metre diamond drilling program at the Yarindury East prospect, targeting magnetic anomalies prospective for porphyry‑style copper and gold. TLM also earns an uncapped 1 per cent royalty on the Wonmunna iron ore project, providing steady cash flow to fund exploration. With healthy cash reserves and royalty revenue, TLM is well‑funded, but remains a speculative investment until assay results confirm shallow gold or porphyry mineralisation.

SELL RECOMMENDATIONS

SELL – Mineral Resources (MIN)

MIN is a diversified resources company, with extensive operations in lithium, iron ore, energy and mining services across Western Australia. The company delivered strong operational results in the first quarter of 2026, which included record iron ore output from Onslow Iron, triggering a $200 million payment. MIN’s joint venture lithium terms with POSCO Holdings will realise it an upfront payment of $A1.2 billion for part of MIN’s lithium business. MIN’S shares have risen from $14.40 on April 9 to trade at $51.90 on December 11. With most of the upside seemingly priced in and commodity cycles still volatile, it may be prudent to cash in some gains made on the strong share price recovery

SELL – Woolworths Group (WOW)

The supermarket giant’s full year 2025 results fell short of market expectations, highlighting margin pressure and subdued sales growth. WOW was recently trading on a lofty price/earnings ratio of about 37 times, which leaves limited upside, in our view. Rising costs combined with subdued discretionary spending suggest growth and profitability may remain constrained. We believe much of the upside is already priced in, so investors may want to consider taking some gains in a high cost, low growth environment.

Don’t Buy Just Yet

You will want to see this before you make any decisions.

Before you decide which shares to add to your portfolio you might want to take a look at this special report we recently published.

Our experts picked out The 5 best ASX shares to buy in 2025.

We’re giving away this valuable research for FREE.

Click below to secure your copy

Related Articles:

• A Beginner’s Guide to CFD Trading in Australia
• How to Start Stock Trading in Australia
• The Best CFD Trading Platform in Australia
• The Best Auto Trading Platforms in Australia

The above recommendations are general advice and don’t take into account any individual’s objectives, financial situation or needs. Investors are advised to seek their own professional advice before investing. Please note that TheBull.com.au simply publishes broker recommendations on this page. The publication of these recommendations does not in any way constitute a recommendation on the part of TheBull.com.au. You should seek professional advice before making any investment decisions.